Last Price | 168.90 | Max Price | 186.60 |
Min Price | 111.00 | 1 Year return | 5.73 |
Sector | Health Care | Subsector | Pharmaceuticals |
Annual report 2015 |
Contact info:Street: Lautrupbjerg 7Postbox: 2750City: BallerupCountry: DenmarkPhone: 45-45750000Email: info@gn.comWebsite: www.gn.comCEO: Niels SvenningsenCFO: Anders BoyerSoegaard
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 12,574 | 615,634 | 2.04 % |
2020 | 13,449 | 638,070 | 2.11 % |
2021 | 15,775 | 727,968 | 2.17 % |
2022 | 18,687 | 787,273 | 2.37 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
GN Store Nord has located her head office Ballerup. GN Store Nord is active in the pharmaceutical sector. Niels Svenningsen is the company' CEO. The CFO of the company is Anders BoyerSoegaard. The past 10 years the (international) industry gained at around 75 percent. Since 2011 the sector is 147 percent higher and over the past year minus 75 percent.
The period between December 2015 and December 2016 was a good period for the investors. The stock gained almost 21 percent. Over the period 2011-2016 the stock rose a massive 207,97 percent. GN Store Nord's revenues between 2011 and 2015 were quite unstable and moved between 3,35 billion euros and 1,45 billion euros. During 2011 and 2015 GN Store Nord's net results were very volatile and fluctuated between 865 million euros and 805 million euros.
The Danish company paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 3,49 percent.
The Danish company had ultimo 2015 approximately 5075 thousand employees on it's payroll.
As per the end of 2015 the Danish company's balance sheet equaled 11,18 billion euros. Of the total balance sheet 5,41 billion euros (48,43 percent) was financed by debt. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 23. So the stock' value was 23 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the Danish stock can be seen as a value stock.
At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the pharmaceutical company equaled around 25,04 billion euros. At the end of 2015 the Danish company had around 202,6 million stocks listed.
All the annual reports of GN Store Nord are available here. More information about GN Store Nord can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
8,404
|
8,651
|
9,585
|
10,607
|
12,574
|
13,449
|
Costs |
7,599
|
7,618
|
8,402
|
9,366
|
11,120
|
12,197
|
Profit |
805
|
1,033
|
1,183
|
1,241
|
1,454
|
1,252
|
Margin of profit |
9.58
|
11.94
|
12.34
|
11.70
|
11.56
|
9.31
|
ROI |
13.97
|
18.38
|
24.73
|
24.35
|
29.99
|
24.18
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
5,764
|
5,620
|
4,783
|
5,096
|
4,849
|
5,178
|
Debt |
5,412
|
7,215
|
6,954
|
7,921
|
11,834
|
11,504
|
Total assets |
11,176
|
12,835
|
11,737
|
13,017
|
16,683
|
16,682
|
Solvency |
51.57
|
43.79
|
40.75
|
39.15
|
29.07
|
31.04
|
Cash |
132
|
178
|
526
|
636
|
1,728
|
1,657
|
Cashflow |
1,450
|
1,803
|
1,885
|
2,072
|
2,207
|
3,206
|
Employees |
4,425
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
1.90
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.27
|
0.25
|
0.27
|
0.26
|
0.19
|
0.28
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
125.30
|
146.30
|
200.50
|
243.30
|
313.30
|
Eps |
6.96
|
8.45
|
9.13
|
10.98
|
9.63
|
Price/earnings-ratio |
18.00
|
17.31
|
21.96
|
22.16
|
17.54
|
Dividend |
1.15
|
1.25
|
1.35
|
1.45
|
1.45
|
Dividend % |
0.92 %
|
0.85 %
|
0.67 %
|
0.60 %
|
0.86 %
|
Payout % |
0.17
|
0.15
|
0.15
|
0.13
|
0.15
|
Book value |
39.17
|
35.05
|
38.44
|
37.60
|
40.15
|
Market to book |
0.31
|
0.24
|
0.19
|
0.15
|
0.24
|
Cashflow per stock |
12.57
|
13.82
|
15.63
|
17.11
|
24.86
|
Stocks |
143
|
136
|
133
|
129
|
129
|
Market Cap |
17.976.92
|
19.961.60
|
26.581.49
|
31.374.02
|
21.783.88
|
Date
|
Price
|
---|---|
22 Apr 2024
|
168.90
|
18 Apr 2024
|
168.90
|
17 Apr 2024
|
166.95
|
09 Apr 2024
|
186.60
|
05 Apr 2024
|
184.95
|
03 Apr 2024
|
178.65
|
30 Mar 2024
|
182.60
|
22 Mar 2024
|
179.05
|
18 Mar 2024
|
159.70
|
15 Mar 2024
|
155.60
|
12 Mar 2024
|
152.95
|
11 Mar 2024
|
154.30
|
09 Mar 2024
|
154.30
|
07 Mar 2024
|
154.70
|
01 Mar 2024
|
161.15
|
29 Feb 2024
|
161.50
|
27 Feb 2024
|
166.00
|
22 Feb 2024
|
169.85
|
21 Feb 2024
|
174.25
|
20 Feb 2024
|
177.05
|
15 Feb 2024
|
175.80
|
14 Feb 2024
|
175.00
|
13 Feb 2024
|
180.20
|
09 Feb 2024
|
174.50
|
08 Feb 2024
|
174.50
|
07 Feb 2024
|
162.55
|
06 Feb 2024
|
164.05
|
05 Feb 2024
|
163.25
|
01 Feb 2024
|
163.60
|
31 Jan 2024
|
163.60
|